Equities research analysts at B. Riley Financial initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Get Free Report) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $8.00 price target on the stock. B. Riley Financial’s price target suggests a potential upside of 88.24% from the stock’s current price.
Strata Critical Medical Stock Down 3.0%
NASDAQ SRTA opened at $4.25 on Wednesday. Strata Critical Medical has a one year low of $2.35 and a one year high of $6.02.
About Strata Critical Medical
Featured Articles
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
